指南与共识腹部MRUS

胰腺导管腺癌高风险个体MRI筛查与报告标准化:PRECEDE联盟共识声明

Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
指南 / 共识 · AJR Am J Roentgenol · 2022-07-20

PRECEDE联盟针对胰腺导管腺癌高风险个体,制定标准化MRI筛查方案与报告模板的共识声明,旨在提高筛查检查质量、改善临床管理一致性并促进多机构研究,联盟由北美、欧洲和亚洲40个中心的专家组成。

要点

  • 胰腺导管腺癌高风险个体定义为符合胰腺癌家族史和/或携带已知胰腺癌风险致病性胚系变异基因标准者。
  • 高风险个体推荐定期接受MRI和/或内镜超声筛查,但不推荐对一般人群进行筛查。
  • 标准化MRI方案和报告模板有助于提高筛查检查质量、改善临床管理一致性并促进多机构研究。

核心结论

  • PRECEDE联盟提出共识声明,以标准化胰腺癌高风险个体的MRI筛查和报告,促进早期诊断、提高生存率并支持多机构研究。

研究设计与样本

  • 共识声明由PRECEDE联盟制定,联盟成立于2018年,由北美、欧洲和亚洲40个中心的胃肠病学家、遗传学家、胰腺外科医生、放射科医生、统计学家和研究人员组成。

诊断标准与关键数值

  • 高风险个体定义为符合基于胰腺导管腺癌家族史和/或携带已知胰腺癌风险致病性胚系变异基因标准者。
  • 高风险个体推荐定期接受MRI和/或内镜超声筛查。
  • 不推荐对一般人群进行胰腺导管腺癌筛查。

临床应用与阅片要点

  • 使用标准化MRI方案和报告模板进行高风险个体筛查,以提高检查质量和临床管理一致性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, with a dismal survival rate. Screening the general population for early detection of PDAC is not recommended, but because early detection improves survival, high-risk individuals, defined as those meeting criteria based on a family history of PDAC and/or the presence of known pathogenic germline variant genes with PDAC risk, are recommended to undergo screening with MRI and/or endoscopic ultrasound at regular intervals. The Pancreatic Cancer Early Detection (PRECEDE) Consortium was formed in 2018 and is composed of gastroenterologists, geneticists, pancreatic surgeons, radiologists, statisticians, and researchers from 40 sites in North America, Europe, and Asia. The overarching goal of the PRECEDE Consortium is to facilitate earlier diagnosis of PDAC for high-risk individuals to increase survival of the disease. A standardized MRI protocol and reporting template are needed to enhance the quality of screening examinations, improve consistency of clinical management, and facilitate multiinstitutional research. We present a consensus statement to standardize MRI screening and reporting for individuals with elevated risk of pancreatic cancer.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Huang, Simeone, Luk, et al. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium. AJR Am J Roentgenol. 2022. PMID: 35856454. doi:10.2214/AJR.22.27859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。